Key result
Postmenopausal estrogen use links to lower cholesterol but higher triglycerides compared to nonuse.
Cross-Sectional (n=1,496)
Answers are grounded in this paper and cite their sources.
A population of 1,496 women aged 55 to 74 years was studied for the distribution of heart disease risk factors in the presence or absence of postmenopausal estrogens. Current hormone use was reported by 39%. Hormone users were significantly slimmer than nonusers at all ages. After adjustment for the effect of obesity, hormone users had significantly lower mean levels of plasma cholesterol and higher mean levels of plasma triglycerides than nonusers. Blood pressure and fasting plasma glucose concentration tended to be lower among hormone users, although the differences were not statistically significant in all age groups. This article discusses the theoretical implications of these observations for cardiovascular disease mortality and contrasts them with the cancer risk of postmenopausal estrogen use.
No takes yet. Share an insight, caveat, or question.
Elizabeth Barrett‐Connor (1979) conducted a cross-sectional in Postmenopausal women evaluated for heart disease risk factors (n=1,496). Postmenopausal estrogen use vs. Nonuse of postmenopausal estrogens was evaluated on Heart disease risk factors (obesity, plasma cholesterol, plasma triglycerides, blood pressure, and fasting plasma glucose). Postmenopausal estrogen use was associated with lower plasma cholesterol and higher plasma triglycerides than nonuse after adjusting for obesity.
Synapse has enriched 10 related papers. Consider them for comparative context: